CLVS
Charles Schwab’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-58,000
| Closed | -$70K | – | 3590 |
|
|
2022
Q3 | $70K | Sell |
58,000
-515,476
| -90% | -$622K | ﹤0.01% | 3263 |
|
|
2022
Q2 | $1.03M | Sell |
573,476
-354,766
| -38% | -$639K | ﹤0.01% | 2780 |
|
|
2022
Q1 | $1.88M | Buy |
928,242
+76,620
| +9% | +$155K | ﹤0.01% | 2664 |
|
|
2021
Q4 | $2.31M | Buy |
851,622
+105,553
| +14% | +$286K | ﹤0.01% | 2657 |
|
|
2021
Q3 | $3.33M | Buy |
746,069
+42,824
| +6% | +$191K | ﹤0.01% | 2563 |
|
|
2021
Q2 | $4.08M | Buy |
703,245
+38,911
| +6% | +$226K | ﹤0.01% | 2443 |
|
|
2021
Q1 | $4.66M | Buy |
664,334
+90,535
| +16% | +$636K | ﹤0.01% | 2335 |
|
|
2020
Q4 | $2.76M | Sell |
573,799
-387
| -0.1% | -$1.86K | ﹤0.01% | 2500 |
|
|
2020
Q3 | $3.35M | Buy |
574,186
+19,434
| +4% | +$113K | ﹤0.01% | 2272 |
|
|
2020
Q2 | $3.75M | Buy |
554,752
+145,997
| +36% | +$986K | ﹤0.01% | 2161 |
|
|
2020
Q1 | $2.6M | Buy |
408,755
+92,221
| +29% | +$587K | ﹤0.01% | 2158 |
|
|
2019
Q4 | $3.3M | Buy |
316,534
+6,083
| +2% | +$63.4K | ﹤0.01% | 2229 |
|
|
2019
Q3 | $1.22M | Buy |
310,451
+9,006
| +3% | +$35.4K | ﹤0.01% | 2514 |
|
|
2019
Q2 | $4.48M | Buy |
301,445
+10,217
| +4% | +$152K | ﹤0.01% | 2027 |
|
|
2019
Q1 | $7.23M | Buy |
291,228
+13,632
| +5% | +$338K | ﹤0.01% | 1776 |
|
|
2018
Q4 | $4.99M | Sell |
277,596
-2,032
| -0.7% | -$36.5K | ﹤0.01% | 1903 |
|
|
2018
Q3 | $8.21M | Buy |
279,628
+14,702
| +6% | +$432K | 0.01% | 1765 |
|
|
2018
Q2 | $12M | Buy |
264,926
+35,192
| +15% | +$1.6M | 0.01% | 1463 |
|
|
2018
Q1 | $12.1M | Buy |
229,734
+8,810
| +4% | +$465K | 0.01% | 1357 |
|
|
2017
Q4 | $15M | Buy |
220,924
+11,030
| +5% | +$750K | 0.01% | 1191 |
|
|
2017
Q3 | $17.3M | Buy |
209,894
+20,267
| +11% | +$1.67M | 0.02% | 1039 |
|
|
2017
Q2 | $17.8M | Buy |
189,627
+14,961
| +9% | +$1.4M | 0.02% | 953 |
|
|
2017
Q1 | $11.1M | Buy |
174,666
+30,623
| +21% | +$1.95M | 0.01% | 1242 |
|
|
2016
Q4 | $6.4M | Buy |
144,043
+8,307
| +6% | +$369K | 0.01% | 1572 |
|
|
2016
Q3 | $4.89M | Buy |
135,736
+30,550
| +29% | +$1.1M | 0.01% | 1664 |
|
|
2016
Q2 | $1.44M | Buy |
105,186
+3,444
| +3% | +$47.3K | ﹤0.01% | 2213 |
|
|
2016
Q1 | $1.95M | Buy |
101,742
+3,745
| +4% | +$71.9K | ﹤0.01% | 2061 |
|
|
2015
Q4 | $3.43M | Buy |
97,997
+2,797
| +3% | +$97.9K | ﹤0.01% | 1758 |
|
|
2015
Q3 | $8.76M | Buy |
95,200
+11,106
| +13% | +$1.02M | 0.01% | 1084 |
|
|
2015
Q2 | $7.39M | Buy |
84,094
+2,777
| +3% | +$244K | 0.01% | 1268 |
|
|
2015
Q1 | $6.04M | Buy |
81,317
+4,105
| +5% | +$305K | 0.01% | 1379 |
|
|
2014
Q4 | $4.32M | Buy |
77,212
+2,864
| +4% | +$160K | 0.01% | 1548 |
|
|
2014
Q3 | $3.37M | Buy |
74,348
+5,233
| +8% | +$237K | 0.01% | 1659 |
|
|
2014
Q2 | $2.86M | Buy |
69,115
+9,954
| +17% | +$412K | ﹤0.01% | 1771 |
|
|
2014
Q1 | $4.1M | Buy |
59,161
+2,037
| +4% | +$141K | 0.01% | 1490 |
|
|
2013
Q4 | $3.44M | Buy |
57,124
+13,181
| +30% | +$794K | 0.01% | 1557 |
|
|
2013
Q3 | $2.73M | Buy |
43,943
+4,172
| +10% | +$259K | 0.01% | 1651 |
|
|
2013
Q2 | $2.77M | Buy |
+39,771
| New | +$2.77M | 0.01% | 1533 |
|